Genmab A/s
(NASDAQ) GMAB
Genmab A/s Financials at a Glance
Market Cap
$15.99B
Revenue (TTM)
$8.84B
Net Income (TTM)
$2.61B
EPS (TTM)
$1.33
P/E Ratio
20.07
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$26.88
Volume
78,176
Open
$26.87
Price
$26.88
Volume
78,176
Open
$26.87
Previous Close
$26.88
Daily Range
$26.68 - $27.02
52-Week Range
$20.23 - $35.43
Dividend
$0.00
Beta (Volatility)
0.72 (Low)
Price
$26.88
Volume
78,176
Open
$26.87
Previous Close
$26.88
Daily Range
$26.68 - $27.02
52-Week Range
$20.23 - $35.43
GMAB News
GMAB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Genmab A/s
Industry
Biotechnology
Sector
Health CareEmployees
3,088
CEO
Jan G. J. van de Winkel, PhD
Website
www.genmab.comHeadquarters
Copenhagen, 1560, DK
GMAB Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
40%
Net Income Margin
18%
Return on Equity
15%
Return on Capital
51%
Return on Assets
21%
Earnings Yield
4.98%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$15.99B
Shares Outstanding
594.91M
Volume
78.18K
Avg. Volume
1.82M
Financials (TTM)
Gross Profit
$3.41B
Operating Income
$1.25B
EBITDA
$1.32B
Operating Cash Flow
$1.19B
Capital Expenditure
$37.03M
Free Cash Flow
$1.15B
Cash & ST Invst.
$1.71B
Total Debt
$5.43B
Genmab A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$899.32M
+25.8%
Gross Profit
$834.08M
+23.9%
Gross Margin
92.75%
N/A
Market Cap
$15.99B
N/A
Market Cap/Employee
$6.06M
N/A
Employees
2,638
N/A
Net Income
$53.20M
-72.7%
EBITDA
$225.83M
-14.8%
Quarterly Fundamentals
Net Cash
$3.83B
-122.0%
Accounts Receivable
$1.03B
-83.7%
Inventory
$21.00M
-74.5%
Long Term Debt
$5.06B
+504.7%
Short Term Debt
$311.00M
+206.7%
Return on Assets
21.14%
N/A
Return on Invested Capital
50.76%
N/A
Free Cash Flow
$2.01M
-100.1%
Operating Cash Flow
$3.01M
-99.8%